These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection. van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607 [TBL] [Abstract][Full Text] [Related]
23. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. Graham BS; Bunton LA; Wright PF; Karzon DT J Clin Invest; 1991 Sep; 88(3):1026-33. PubMed ID: 1909350 [TBL] [Abstract][Full Text] [Related]
24. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines. Fuentes S; Arenas D; Moore MM; Golding H; Khurana S Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627 [TBL] [Abstract][Full Text] [Related]
25. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection. Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446 [TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin administration and ribavirin therapy: efficacy in respiratory syncytial virus infection of the cotton rat. Gruber WC; Wilson SZ; Throop BJ; Wyde PR Pediatr Res; 1987 Mar; 21(3):270-4. PubMed ID: 3550674 [TBL] [Abstract][Full Text] [Related]
27. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522 [TBL] [Abstract][Full Text] [Related]
28. Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice. Remot A; Descamps D; Jouneau L; Laubreton D; Dubuquoy C; Bouet S; Lecardonnel J; Rebours E; Petit-Camurdan A; Riffault S Eur J Immunol; 2016 Apr; 46(4):874-84. PubMed ID: 26681580 [TBL] [Abstract][Full Text] [Related]
29. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131 [TBL] [Abstract][Full Text] [Related]
30. Studies on the pathogenesis and interspecies transmission of respiratory syncytial virus isolated from sheep. Bryson DG; Evermann JF; Liggitt HD; Foreyt WJ; Breeze RG Am J Vet Res; 1988 Aug; 49(8):1424-30. PubMed ID: 3178037 [TBL] [Abstract][Full Text] [Related]
31. Association of bovine respiratory syncytial virus with atypical interstitial pneumonia in feedlot cattle. Collins JK; Jensen R; Smith GH; Flack DE; Kerschen R; Bennett BW; Jones RL; Alexander AF Am J Vet Res; 1988 Jul; 49(7):1045-9. PubMed ID: 2458690 [TBL] [Abstract][Full Text] [Related]
32. A lamb model for human respiratory syncytial virus infection. Lapin CD; Hiatt PW; Langston C; Mason E; Piedra PT Pediatr Pulmonol; 1993 Mar; 15(3):151-6. PubMed ID: 8327277 [TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of severe acute respiratory infections in the developing world: respiratory syncytial virus and parainfluenza viruses. McIntosh K Rev Infect Dis; 1991; 13 Suppl 6():S492-500. PubMed ID: 1650494 [TBL] [Abstract][Full Text] [Related]
34. Experimental infection of lambs with bovine respiratory syncytial virus and Pasteurella haemolytica: clinical and microbiologic studies. Al-Darraji AM; Cutlip RC; Lehmkuhl HD; Graham DL; Kluge JP; Frank GH Am J Vet Res; 1982 Feb; 43(2):236-40. PubMed ID: 7091825 [TBL] [Abstract][Full Text] [Related]
35. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice. Vaux-Peretz F; Chapsal JM; Meignier B Vaccine; 1992; 10(2):113-8. PubMed ID: 1539464 [TBL] [Abstract][Full Text] [Related]
36. IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease. Castilow EM; Meyerholz DK; Varga SM J Immunol; 2008 Feb; 180(4):2376-84. PubMed ID: 18250447 [TBL] [Abstract][Full Text] [Related]
37. Mycoplasma bovis infection in gnotobiotic calves and combined infection with respiratory syncytial virus. Thomas LH; Howard CJ; Stott EJ; Parsons KR Vet Pathol; 1986 Sep; 23(5):571-8. PubMed ID: 3535220 [TBL] [Abstract][Full Text] [Related]